Loading...
XSWXVBSN
Market cap397mUSD
Dec 23, Last price  
150.00CHF
1D
0.00%
1Q
5.63%
Jan 2017
-26.00%
IPO
76.37%
Name

IVF Hartmann Holding AG

Chart & Performance

D1W1MN
XSWX:VBSN chart
P/E
23.58
P/S
2.41
EPS
6.36
Div Yield, %
1.68%
Shrs. gr., 5y
0.20%
Rev. gr., 5y
1.99%
Revenues
148m
-1.79%
108,719,000113,614,000108,354,000106,717,000103,956,000113,673,000117,608,000118,594,000125,998,000125,434,000132,939,000132,288,000134,693,000133,449,999134,049,000137,998,000172,919,000144,067,000150,649,000147,953,000
Net income
15m
+34.95%
3,750,0004,281,0004,423,0004,754,0006,188,00010,359,00012,380,00013,166,00014,815,00015,346,00015,777,00016,091,00016,447,00016,010,00014,070,00012,169,00017,825,0006,209,00011,225,00015,148,000
CFO
34m
+90.90%
11,406,00010,032,00010,397,0004,993,00012,261,00010,321,00016,317,00015,982,00015,815,00017,775,00016,771,00020,642,00018,488,00016,642,00013,444,00018,020,00030,888,000-2,511,00017,719,00033,825,000
Dividend
Apr 25, 20245 CHF/sh
Earnings
Mar 04, 2025

Profile

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses. It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.
URL
https://www.ivf.hartmann.info
IPO date
Jul 16, 2012
Employees
293
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
147,953
-1.79%
150,649
4.57%
144,067
-16.69%
Cost of revenue
102,968
106,732
110,206
Unusual Expense (Income)
NOPBT
44,985
43,917
33,861
NOPBT Margin
30.40%
29.15%
23.50%
Operating Taxes
2,759
1,925
998
Tax Rate
6.13%
4.38%
2.95%
NOPAT
42,226
41,992
32,863
Net income
15,148
34.95%
11,225
80.79%
6,209
-65.17%
Dividends
(6,000)
(4,560)
(8,400)
Dividend yield
2.23%
1.61%
2.88%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
487
427
458
Long-term debt
1,708
1,008
856
Deferred revenue
(1)
Other long-term liabilities
605
689
798
Net debt
(85,721)
(38,380)
(28,032)
Cash flow
Cash from operating activities
33,825
17,719
(2,511)
CAPEX
(2,420)
(2,706)
(6,443)
Cash from investing activities
20,437
(2,678)
(6,420)
Cash from financing activities
(6,000)
(4,560)
(8,400)
FCF
37,286
44,872
17,781
Balance
Cash
87,916
39,815
29,346
Long term investments
Excess cash
80,518
32,283
22,143
Stockholders' equity
151,376
143,673
137,008
Invested Capital
72,804
112,304
116,549
ROIC
45.62%
36.70%
30.19%
ROCE
28.85%
29.75%
23.93%
EV
Common stock shares outstanding
2,401
2,374
2,374
Price
112.00
-6.28%
119.50
-2.85%
123.00
-34.22%
Market cap
268,871
-5.23%
283,697
-2.85%
292,032
-34.24%
EV
183,150
245,317
264,000
EBITDA
50,507
50,028
39,398
EV/EBITDA
3.63
4.90
6.70
Interest
19
343
458
Interest/NOPBT
0.04%
0.78%
1.35%